NEW YORK - TelAve -- New York, NY, – Age Reversal Unity is calling attention to the FDA's failure to respond to its citizen petition, submitted on May 22, 2024, requesting that aging be classified as a disease. The FDA was required to respond within 180 days but has yet to do so.

The petition advocates for the recognition of aging as a medical condition that could benefit from targeted research and treatments. By classifying aging as a disease, Age Reversal Unity believes more resources, funding, and regulatory support could be directed toward innovative solutions for age-related health issues, potentially improving the lives of millions of aging Americans.

"The FDA's delay in responding to this petition is a setback in the fight against age-related diseases," said Age Reversal Unity. "Recognizing aging as a disease would empower researchers to develop life-changing treatments, and we urge the FDA to act immediately."

More on TelAve News

• Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
• Canadian Tint Expo 2027: Why Every Window Tinter Should Compete in Niagara Falls on April 3rd & 4th
• MobileSphere Index Finds Mobile Numbers Are Becoming the New Digital Identity
• Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
• Most Indiana Plane Crashes Happen Away from the State's Major Airports

Aging is the primary risk factor for major diseases like Alzheimer's, cardiovascular disease, and cancer. Age Reversal Unity argues that addressing aging could unlock new pathways for medical advancements and improve public health.

The company calls on the FDA to fulfill its legal obligation and respond to the petition, which has received widespread support from experts in aging research.

For more information about Age Reversal Unity and its ongoing efforts to promote age-related research and policy, please visit this link agereversalunity.com